Centers for Medicare & Medicaid Services
[[CentersForMedicareAndMedicaidServices|Centers for Medicare & Medicaid Services]] appears in Tyler Shultz, Theranos Whistleblower (Part 2) as one of the regulators that inspected Theranos after the [[WallStreetJournal|Wall Street Journal]] reporting. The episode refers to the agency as CMS and says its inspections helped validate concerns [[TylerShultz|Tyler Shultz]] had been unable to make the company accept internally.
In Tyler’s account, CMS found lab practices that put patient health in immediate jeopardy, and inspectors found records showing quality controls failed while patient samples were still run. The page therefore connects CMS to Medical Testing Validation Integrity: diagnostics governance depends on regulators seeing real quality-control evidence rather than a staged or incomplete inspection surface.
Connections
- Theranos, [[TylerShultz|Tyler Shultz]], and [[ElizabethHolmes|Elizabeth Holmes]] - company, source witness, and executive context.
- [[FoodAndDrugAdministration|Food and Drug Administration]] - co-regulator named in the episode’s fallout section.
- [[WallStreetJournal|Wall Street Journal]] and [[JohnCarreyrou|John Carreyrou]] - reporting path that preceded inspections.
- Medical Testing Validation Integrity, Startup Governance, and Public Service Journalism - patient-risk, oversight, and accountability concepts.